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Wonderful, awful, say what you will, Social Media—while it may not be here forever—is defi nitely 
amongst us for the near future.  Everyone from university presidents to United States presidents
are tweeƟ ng away.  It is about communicaƟ on—geƫ  ng the word out (more than imagined 
possible), educaƟ on, interacƟ on, distracƟ on, and dislocaƟ on.  It can evince the best and the worst
in us.  
The public can compare physicians, ask medical quesƟ ons; scienƟ sts can access scienƟ fi c journals; 
long lost friends can meet and greet across the sea. From a personal standpoint, a bit 
of advice from our resident tech guru Carlos Zepeda, who notes “basically use commonsense
about what you post and what you are comfortable with the rest of the world seeing”... and that 
means friends, colleagues, and potenƟ al employers.
One challenge from the insƟ tuƟ onal perspecƟ ve is how to stay current with limited person power 
and staﬀ  Ɵ me—yet maintain a face and place in the social/academic swim.  The urgency of 
conƟ nually populaƟ ng something like Facebook on a regular (daily, weekly, minute to minute) 
basis for an insƟ tuƟ on is a bit like keeping up with carnivorous plant Audrey II in LiƩ le Shop of
Horrors crying, “Feed me, feed me” with the newest photos, facts, and general informaƟ on. 
Faculty were recently surveyed about the impact of social media and technology on the conduct 
of even research studies with human subjects—this becomes very important indeed. 
Below is a sample of our own University of Texas Graduate School of Biomedical Sciences social 
media and technical presence—feel free to sample.
While accessible through either The University of Texas Health Science Center (UTHealth) or 
The University of Texas M. D. Anderson Cancer Center (M.D. Anderson), the easiest way to get
started is to log onto the GSBS website directly: www.uthouston.edu/gsbs.
Check out the GSBS page on Facebook           or access it from UTHealth or M. D. Anderson sites.
Hit the “Make a GiŌ ” buƩ on if that is your desire.
Log-in to the new Alumni community website www.utgsbsalumni.org  for the ability to update 
your own professional/personal informaƟ on, seek out your classmates, or enjoy reunion photos.
(There’s a sign-up reminder card in this issue of the newsleƩ er).
Finally, follow us on iTunesU by clicking on our website     to enjoy the most recent 
Commencement proceedings live, or take in a scienƟ fi c seminar—free of charge.  
A sonnet to close our comments about social media, “Magister Luminous:”
Reprinted here from the August 25, 2010 Chronicle for Higher EducaƟ on, with permission of the author, Jack Roundy, Ph.D., 
Director of Academic Advising, University of Puget Sound.
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Message to the Alumni:
Joy Marshall, Ph. D.
President 2009-2010















There, at the shoulder of an elder turns
The youth toward a fl at pad in her hand
In her eyes its blue refl ecƟ on burns,
Its pixels bearing views of Samarkand.
What depths beneath that pane of glass may lie
The casual observer cannot see
Or read what images or ciphers ply
Their voyages across her cyber sea.
Beside the youth immersed within her glow
The elder writes his ciphers on a board,
Building his chalk edifi ce row on row
Then standing back, assessing their accord.
He turns to her, but will she turn to him
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By the Ɵ me you read this many of you will already have seen, 
or will soon see, the new logos rolled out by our two parent 
insƟ tuƟ ons, M. D. Anderson and UTHealth.  It is preƩ y obvious 
that both send a strong message about their missions.   The red 
line in M. D. Anderson’s logo illustrates the progress and
commitment to Making Cancer History™ and UTHealth’s 
indicates a comprehensive health sciences university 
dedicated to improving the health of the populaƟ on.  I had 
the opportunity to parƟ cipate in discussions about developing 
both of these logos and the process was very
educaƟ onal, especially listening to the in-house professionals
and outside consultants who are experts in design, 
markeƟ ng, and insƟ tuƟ onal branding.
In the process I learned that a logo should be more than a 
visually appealing symbol that makes an impression, hopefully 
a lasƟ ng one, on the viewer and is useful for markeƟ ng 
purposes.  Certainly it should be that, but I came to appreciate 
that it should be something more.  So what else should a logo 
be?  A logo is a visible part of an overall eﬀ ort that the markeƟ ng 
and adverƟ sing world calls branding that is just what it sounds 
like—it’s about creaƟ ng a “brand” that marks an insƟ tuƟ on. 
A brand tells people about the essence of an insƟ tuƟ on and 
indicates what it values; this is something most of us probably 
understand insƟ ncƟ vely.  What I learned that had not previously
occurred to me, however, is that a brand also 
indicates a promise made by an organizaƟ onal enƟ ty to both 
the public and its internal consƟ tuencies.  M. D. Anderson is 
essenƟ ally promising that it is working to cure and prevent 
cancer and UT Health is promising that its six schools, including 
GSBS, are working together to oﬀ er the best hope to improve 
peoples’ health.  These are preƩ y powerful promises, but in 
line I believe with the strengths of our parents’ resources, 
capabiliƟ es, intenƟ ons, and commitments.   They also make me 
feel great pride in being part of both insƟ tuƟ ons.  
These promises also apply to GSBS.  Under the brands of our 
two parent insƟ tuƟ ons we are, in eﬀ ect, promising the public 
and our students that we are dedicated to teaching the best 
research methods and approaches that will lead to
fundamental discoveries in the biomedical sciences.  This is 
the same mission we had when our School was founded nearly 
50 years ago and remains fi rmly in place.  Apropos to the two 
new logos we now promise something more: to increasingly 
help translate discoveries into eliminaƟ ng cancer and 
improving the overall health of the public.   I fi rmly believe that
no school is beƩ er posiƟ oned than GSBS to fulfi ll this promise 
to the public and its students.  I am energized and excited 
by our new logos, brands, and promises.
Logos, Brands, and Promises
      GSBS Alumni AssociaƟ on and Graduate Student AssociaƟ on
CAREER DAY
Saturday, June 12, 2010
Ben  Thomas, Ph.D.
(1973)
Orlando Saldana, M.B.A.
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Address               President of UTHealth
Good morning. First, let me say what a privilege it is for me to 
be here today to congratulate all of you and to recognize the 
hard work that got you where you are today. I stand in awe of 
your accomplishments and all of you should take tremendous 
pride in geƫ  ng here today. I know that for many of you the 
road has been a long one and yet today represents just the 
beginning. But there is no quesƟ on that it is an exciƟ ng Ɵ me to 
begin. A recent report from the Commission on the Future of 
Graduate EducaƟ on in the United States enƟ tled, “The Path 
Forward” concluded, “graduate educaƟ on plays a criƟ cal role in 
today’s world and will conƟ nue to do so in the future. A beƩ er 
understanding of that role and a clear path forward depend 
upon eﬀ ecƟ ve collaboraƟ ons between universiƟ es, industry, and 
government. Finding soluƟ ons to 21st century challenges, 
ensuring conƟ nued naƟ onal prosperity and maintaining our 
posiƟ on in the global economy will require a highly skilled, 
creaƟ ve and innovaƟ ve workforce. These creaƟ ve innovators 
will be the product of the U.S. graduate educaƟ on system.” 
The key assumpƟ on is that the compeƟ Ɵ veness of the US and 
our naƟ on’s capacity for innovaƟ on hinge fundamentally on a 
strong system of graduate educaƟ on. 
Our Graduate School is now in its 47th year of existence and it
is novel in many ways. As you may already be aware, many 
insƟ tuƟ ons like ours do not have formal graduate schools as 
such but usually mix in the graduate program in biomedical 
sciences with the Medical School. Our structure gives us the 
tremendous advantage of being able to draw faculty 
from all of our Schools and, of course, from The University 
of Texas M. D. Anderson Cancer Center (MDACC). 
Basic science forms the foundaƟ on of much of the• 
work done in the other fi ve schools of the University of Texas 
Health Science Center at Houston (UTHealth) and all other health 
related insƟ tuƟ ons.
Basic discoveries that lead to intellectual property and real • 
world products are important and valuable to the public, our 
university, and the discoverer’s department as well as the
individual inventor – this source of revenue is criƟ cal to allow
 insƟ tuƟ ons like ours to conƟ nue to fl ourish. 
It was only in 1980 that the Bayh-Dole Act was passed that • 
gave U.S. universiƟ es, small businesses, and non-profi ts control 
of intellectual property that resulted from invenƟ ons or • 
discoveries that arose from federally funded research. Needless 
to say this has been and conƟ nues to be a considerable source 
of revenue for many universiƟ es. InteresƟ ngly prior to the 
Bayh-Dole Act the US government had accumulated 30,000 
patents of which only about 5% were commercially licensed. 
Since knowledge in the basic sciences is so important • 
to progress in health and many other areas, it is our 
responsibility to train the next generaƟ on of research
invesƟ gators—that’s what 
you are —and that’s why 
we’re here today to honor 
you. 
Increasingly basic sci-• 
enƟ sts are also part of 
clinical and translaƟ onal 
research teams that are 
criƟ cal to more eﬀ ecƟ vely 
and eﬃ  ciently move new 
discoveries from the labo-
ratory to the clinic where 
real lives can benefi t.  I’m 
pleased to see that recent-
ly our Center for Clinical 
and TranslaƟ onal Sciences 
and MD/PhD programs, both of which involve our two
insƟ tuƟ ons, MDACC and UTHealth, are providing special 
impetus and support for this clinical and transalaƟ onal research 
training eﬀ ort.  I’m very pleased to see this eﬀ ort along with our 
conƟ nuing eﬀ ort in basic fundamental biomedical discovery.
Finally, and criƟ cally important, is that our GSBS is an • 
organizaƟ onal model that is unique and has shown how • 
we can merge the resources of two strong UT components, 
UTHealth and MDACC, to synergisƟ cally create one enƟ ty that 
is far beƩ er able to educate young scienƟ sts than either one 
could alone.  There is no place like this in the TMC, the UT 
System, Texas, or the naƟ on and I really believe GSBS is a model 
of the kind of cooperaƟ on that will be criƟ cal to maximize our 
research and educaƟ on in more and more of our insƟ tuƟ ons. 
And it’s people like the GSBS Faculty, student body, staﬀ , and • 
administraƟ ve leaders that make this system work and enable 
it to overcome the challenges that frequently surface. No, it’s 
not always easy but the value of the combined enterprise far 
outweighs whatever addiƟ onal administraƟ ve diﬃ  culƟ es that 
might ensue. So, I salute you collecƟ vely for providing a model 
demonstraƟ ng to us as well as to other insƟ tuƟ ons how to 
eﬀ ecƟ vely and eﬃ  ciently use resources and maximize
our eﬀ orts.
The main thrust of my remarks this morning deal with the 
future, which is always easy to speak about because at least at the 
present Ɵ me I can’t be wrong. There are those who would argue 
that looking at the past we can predict the future. I came across the 
following quote for which I could not fi nd aƩ ribuƟ on but I think it 
expresses this view opƟ mally: “Telling the future by looking at the 
past assumes that condiƟ ons remain constant. This is like driving a 
car by looking in the rearview mirror.” Needless to say it is a stretch 
to ever make the assumpƟ on that condiƟ ons remain constant. 
NoƟ ce I stayed away from quoƟ ng Yogi Berra mainly because • 
“Go Confi dently in the DirecƟ on of Your Dreams”
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I quoted him in my remarks last evening at the Nursing School 
Commencement. For that maƩ er probably very few of you even 
know who Yogi Berra is but what he is alleged to have said is: 
“It’s tough to make predicƟ ons, especially about the future.” 
Looking at it another way was Lincoln who said, “The best • 
way to predict your future is to create it.”  The idea here 
being that the future will be shaped by knowledge and 
discoveries we’re in the process of making today yet recognizing
the uncertainƟ es that exist. Tennessee Williams in his 1957 play, 
Orpheus Descending, recognizing this uncertainty said, “The 
future is called ‘perhaps’ which is the only possible thing to call the 
future, and the only important thing is not to allow that to
 scare you.”
I think there is truth to both perspecƟ ves, though in our • 
current environment change is occurring so rapidly that trying to 
gauge the future based on the past likely will be diﬃ  cult at best. 
But let me talk fi rst about how discoveries in the past have led 
to benefi ts we enjoy today.  Julius Comroe, one of the most 
disƟ nguished physiologists of the 20th century noted that one 
of the most dramaƟ c events in medicine in the 20th century was 
transplantaƟ on of the human heart. He noted that there was a 
great deal of publicity in the popular press about the race to be 
the fi rst, about ChrisƟ an Barnard “scooping” Norman Shumway, 
with whom Barnard had trained, about how others had done the 
basic work and Barnard just jumped in. But most importantly 
he then went on to note that, notwithstanding the race to be 
fi rst, this incredible accomplishment never would have been 
conceivable, much less doable, without an enormous amount of 
previous basic discoveries by many people. These included the 
discovery of x-rays, angiocardiography, the electrocardiogram,
cardiac catheterizaƟ on and the basic surgical techniques 
developed for open heart surgery such as cardiopulmonary 
bypass, which at that Ɵ me, believe it or not, had been around 
less than 20 years.  Also key were studies by Starling on auto-
regulaƟ on of the heart that demonstrated that a transplanted 
heart without neural connecƟ ons could indeed funcƟ on. This 
in itself was an incredible leap since the thought of completely 
removing the heart from a living person and then replacing 
it with a completed denervated heart from a non-related 
donor leŌ  great doubt as to whether the heart would funcƟ on. 
Basic studies in immunology and pharmacology led to the • 
development of immunosuppressive drugs to prevent rejecƟ on,
drugs that in the early days of transplantaƟ on were fairly 
primiƟ ve and not parƟ cularly eﬀ ecƟ ve.  Many other basic 
discoveries were necessary to allow heart transplantaƟ on to 
become a clinical reality and in fact, aŌ er the fi rst few eﬀ orts 
proved less than successful, there was a several year moratorium 
as invesƟ gators went back to the lab to solve a number 
of problems. 
There are numerous other examples where the pracƟ cal • 
applicaƟ on resulted from the accumulaƟ on of what at one Ɵ me 
appeared to be enƟ rely basic and of academic interest only. 
For that maƩ er who would have thought that looking at yeast
geneƟ cs would have led to the important work in elucidaƟ ng
the human genome, or that fruit fl ies could be used as a
model of neurodegeneraƟ ve disease (and we could go on and 
on with examples). The point being important basic discoveries 
inevitably lead to advances that benefi t society in ways 
that oŌ en are not understood for many years to come. 
That’s why the Graduate School is such an important 
component of the UTHealth and MDACC families. 
Based on these examples and many others we could come up 
with, I’m willing to say fairly confi dently that if we’re doing
good, careful science that leads to beƩ er understanding of 
fundamental principles or develops new intellectual approaches 
or new technology, these discoveries will lead to improvements 
in health and human well being that we can’t even imagine 
today.  Now it doesn’t mean that you can’t make important 
contribuƟ ons doing clinical or translaƟ onal research, or other 
science-related careers including scienƟ fi c wriƟ ng.  It just means 
that society depends upon people like you for a steady stream 
of basic discoveries as an essenƟ al component of progress. 
Well, what about the other perspecƟ ve? That is “the best 
way to predict your future is to create it.”  I am the last one 
to make these sorts of predicƟ ons but as we have moved into 
the era of being able to inexpensively, relaƟ vely speaking
sequence the enƟ re human genome I think it is safe to 
say that we will conƟ nue to see more work done toward 
what we refer to as personalized medicine. We already are 
seeing some examples of this in the marketplace. 
We need to consider more complex levels of biological 
organizaƟ on and funcƟ on.  In the early 20th century the English 
physician Archibald Garrod coined the term “inborn errors of 
metabolism” and proposed the concept that errors in single 
genes led to inherited diseases.  Of course this is true some of 
the Ɵ me but what we’re learning today is that many of our most 
costly human diseases –diabetes, cardiovascular disease, cancer, 
and others—are oŌ en mulƟ -factorial in nature involving many genes 
and their interacƟ on with each other and with the environment. 
So, how are we going to fi gure this all out?  
You may disagree with me, but in my opinion present and future 
discoveries will hinge upon the collecƟ on, storage and 
manipulaƟ on of large amounts of data that allow us to build 
models to predict how biological systems, both normal and 
pathological, funcƟ on.  I have invested heavily in our program in 
biomedical informaƟ cs and it’s already paid dividends. As many 
of you may know we recently were awarded one of only four 
Specialized Health InformaƟ on Advanced Research Projects 
grants to create a naƟ onal center for cogniƟ ve informaƟ cs and 
decision making in healthcare that totaled over $15M.  In addiƟ on, 
we also were awarded one of the Regional Health InformaƟ on 
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Extension Center grants also for $15M.  It’s clear to me that 
informaƟ cs and it’s related sciences are going to lead to discoveries 
to create the future, and I think all of us to be successful are 
going to have to learn how to more eﬀ ecƟ vely and eﬃ  ciently 
use informaƟ c tools no maƩ er what our fi eld of research. 
You probably won’t be surprised if I say that I think new 
discoveries in geneƟ cs are also going to be another criƟ cal 
area for future advances.  Within the past few years we have 
witnessed the ability to rapidly sequence the enƟ re human 
genome. Now just consider that for a moment.  When I was in 
medical school we barely knew the basic structure of human 
genes and now we know the enƟ re genome.  Your generaƟ on now 
starts with this informaƟ on and one can only imagine what you’re 
going to discover during your careers given your starƟ ng point.
I think another major interface that will help create the future 
is that between the physical sciences and the biological ones. 
Bio-engineering, nanotechnology and biophysics combined with 
physiology, pharmacology, biochemistry, geneƟ cs, neuroscience, 
cancer biology and so on. The lines between the basic sciences 
are not just blurring they already are blurred. We have only 
four basic science departments in the Medical School and those 
exist only because of issues of appointment and promoƟ on. 
We could go on and on, and maybe you’d agree with me or not 
on the future importance of any specifi c technological area, 
but I want to make what I think is an even more important, 
overriding point.  With the explosion of informaƟ on and its 
accessibility, few if any of us can simultaneously be an expert 
in more than one area of biomedical science. The world has 
changed and here’s a liƩ le known fact: “Renaissance Men” 
were very rare in the Renaissance, and I’m going to predict that 
Renaissance men and women in the tradiƟ onal sense will likely 
be non-existent in the future—there’s just too much to know. 
So, we are in the midst of an explosion of informaƟ on and as a 
society we need to put it all together, but we can’t do it individually
—we need to work collaboraƟ vely and eﬃ  ciently with a wide 
variety of people who are experts in many diﬀ erent fi elds.  It’s 
obvious to me that communicaƟ on, leadership, and the ability 
to work in teams—with a diversity of people in a variety of fi elds 
and in many diﬀ erent venues—is going to be absolutely criƟ cal in 
order to make real progress in biology, medicine, or any other fi eld. 
There is now and will conƟ nue to be a need for those with • 
an advanced basic science educaƟ on to be scienƟ fi c writers 
and communicators, those who are able to get across 
scienƟ fi c informaƟ on in a way that is accessible to the lay public. 
It should come as no surprise to any of you that we can read 
in the New York Times or the Wall Street Journal about a major 
report that will appear in Science or Nature within the following 
day or two in a way that makes sense even to a non-scienƟ st. 
Some of you will need to work in public policy so that policy 
makers can beƩ er understand how to implement basic scienƟ fi c 
discoveries and how to base decisions on the best science. 
There are many places in our informaƟ on-driven modern • 
society where we’re going to increasingly need well trained 
scienƟ sts.  Take the week’s major news—the oil rig disaster
in the Gulf, BP, the US Coast Guard, the US Navy—all rely on 
basic scienƟ sts and biotech experts, in addiƟ on to engineers,
to solve a myriad of problems from how to cap the well to the 
potenƟ ally disastrous environmental consequences.
Finally, I ask that each of you be intellectually bold!  I believe it is 
important that you not be afraid to envision radically new things 
and try them out.  Resist the urge to stay solely in your comfort 
zone.  Real breakthroughs in any fi eld increasingly occur as the 
result of generaƟ ve thinking, coming up with an enƟ rely new way 
of looking at a problem or perhaps working with people in areas 
where you might have a steep learning curve.  Remember the 
most important thing you should have taken out of your Master’s 
or Doctoral educaƟ on here at GSBS is the ability to think criƟ cally 
and use what you have learned to create new knowledge.  That’s 
far more important than any factoid you’ve learned, some of 
which will be proven to be poorly understood or even fl at wrong 
in the future.  Your criƟ cal thinking skills are the most important 
thing you’re taking away with you from this commencement—
don’t be afraid to use them.  And if you’re sƟ ll worried about 
geƫ  ng out of your comfort zone, realize this: People who are 
entrepreneurs who try new things in medicine, basic science, 
business, or anything else are guaranteed to make mistakes. 
But those who only wish to maintain the status quo make just 
as many mistakes.  You’ve had a great educaƟ on in how to think 
creaƟ vely and criƟ cally—don’t be afraid to use that educaƟ on to 
be bold.  You’ll make mistakes, but you’d make some anyway, 
and on the plus side you’ll learn to fi nd answers to new and truly 
important quesƟ ons.  That’s how progress is ulƟ mately made. 
Your most important task as scienƟ sts is to seek the truth in your 
research and careers in all ways and at all Ɵ mes, without fail. 
Survey aŌ er survey has shown consistently that scienƟ sts are 
among the most trusted and respected professionals in our world, 
and if people ever lose that faith they will not support the science 
and research necessary for progress.  When you leave this room, 
remember that the ciƟ zens of the world admire you, trust you, and 
trust in the results of your work.  I hope that you’ll do everything you 
can to strengthen that legacy for future generaƟ ons of scienƟ sts. 
John M. Richardson, Jr., a Professor at American University who 
is a pioneer in the fi eld of global modeling and system dynamics,
has said, “When it comes to the future, there are three kinds 
of people: those who let it happen, those who make it happen, 
and those who wonder what happened.” Don’t be one of those 
leŌ  wondering. Good luck, farewell, and best wishes.
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CongratulaƟ ons on the successful compleƟ on of your Ph.D. and M.S. 
programs.  These are amongst the highest degrees that our society 
oﬀ ers, and your hard work has earned you these disƟ ncƟ ons forever. 
You should be proud of yourselves, and on behalf of the faculty 
at The University of Texas Graduate School of Biomedical Sciences 
I want to let you know that we are proud of you and convey that we 
have high expectaƟ ons for you as future scienƟ fi c leaders.
This is a special day; a day of celebraƟ on.  And it is truly a pleasure 
to stand up here and recognize many of you whom I have lectured to 
in classes, interacted with at GSBS funcƟ ons, and have trained in my 
laboratory.  You have accomplished so much; you have succeeded. 
I would like to take this opportunity to lecture to you a liƩ le bit more 
and to ask you a quesƟ on, a quesƟ on you might not have thought much 
about: How will you defi ne success in your lives from this day forward?
This is obviously not an easy quesƟ on to answer, but it is one you 
should ponder.  Wikipedia defi nes success as “achievement of an 
objecƟ ve or goal;” however, I submit to you that it means much 
more than this, and that the true defi niƟ on of success is inherently 
individualized.  For example, you are receiving a top degree from one 
of the top insƟ tuƟ ons within the world’s largest Medical Center; you 
have excelled in this “cuƫ  ng edge” environment and have 
accomplished great things.  But, the paths you have taken to get here 
and the struggles you have faced have been varied and have occurred 
in the context of your personal lives.  Clearly many factors contribute 
to success including hard work and opportunity.  However, another 
factor that I feel is a key component of success, is learning to achieve 
balance in your professional endeavors and personal lives.  “Balance” 
is a key factor for a successful and sustainable scienƟ fi c career.
Professionally, choose your paths carefully; do what you love, and love 
what you do.  Find the passion for your science and pursue it with all 
your intellect.  This will impart the moƟ vaƟ on you need to work hard 
and get the data you need for those compeƟ Ɵ ve grants and those high 
profi le publicaƟ ons, which in many scienƟ fi c arenas will contribute 
to your success.  This can be very graƟ fying and a lot of fun, and many 
of you will fi nd that you are very good at it.  However, be careful not 
to lose perspecƟ ve on your way to achieving your scienƟ fi c goals. 
Learn to achieve balance in the way that you think about and promote 
your scienƟ fi c ideas.  As scienƟ sts at this level you are all inherently 
smart and probably very compeƟ Ɵ ve.  These are good traits to have, 
but remember that it is oŌ en not only what you do in science that is 
important, but also who supports your fi ndings that ensure the most 
is made of your accomplishments.  Always respect and acknowledge 
the scienƟ sts who have laid the groundwork for your discoveries 
and give credit to the collaborators and trainees who assist you in 
tesƟ ng your hypotheses.  Respect and acknowledge that there are 
diﬀ erences in opinion when it 
comes to science and realize that 
criƟ cism is an important part of the 
scienƟ fi c process.  Champion your 
fi ndings by arƟ culaƟ ng your 
raƟ onale and backing it up with 
data, but remember that bal-
ancing your opinions with the
opinions of others is an important 
part of achieving scienƟ fi c truth.
In addiƟ on to your professional 
acƟ viƟ es, you will need to seek 
balance in your personal life.  As a working scienƟ st, the 
Ɵ me required to get data, read, think, write and men-
tor is not easily contained in a convenƟ onal work week.  It 
requires long hours and stresses that can easily impact your personal 
life.  You all know what I am talking about; you have been living 
this way as graduate students.  Here you are again—you will 
likely conƟ nue to be very good at this, and may even enjoy it. 
But, you will need to seek balance in your personal life to ensure 
sustained success in your career.  It is very diﬃ  cult for an 
unhappy person to accomplish much, and in our industry you need 
every advantage you can get.  How to accomplish this is obviously a
very personal issue.  Only you know what makes you happy and only 
you can set your prioriƟ es.  I am simply advising that if you have not 
put much thought into how you will balance your personal life and 
professional life, you need to.  On my career path, the support, love 
and happiness that my family and friends have provided has been an 
essenƟ al catalyst for any success I have had.  For example, taking the 
Ɵ me to coach my kids’ soccer teams, traveling with my family, playing 
hard with my friends and being acƟ ve in church have all contributed 
to the balance I need in my life to be happy and be producƟ ve in my 
career.  
In conclusion, you have been well trained to think like scienƟ sts and 
are equipped with the fundamentals you need to solve complex 
scienƟ fi c quesƟ ons and make important contribuƟ ons to our society. 
I charge you to set your goals high.  Abraham Lincoln wrote that you 
should “always bear in mind that your own resoluƟ on to success is 
more important than any other one thing.”  Seek the balance you need 
in your professional and personal lives to achieve success.  At the very 
least ponder the quesƟ on: How will you defi ne success in your life?
So, again I congratulate you on the compleƟ on of your M.S. and 
Ph.D. degrees, and wish you all the very best.  Work hard, be content 
with your successes and have fun.
  MICHAEL BLACKBURN, Ph.D.Commencement Greetings
from gsbs faculty President Graduate Faculty President 2009-2010
The McGovern Award for Outstanding Teaching recognizes a GSBS faculty member, Stephanie Watowich, Ph.D. who has
signifi cantly contributed to the educaƟ on and training of GSBS students. Each year, students nominate faculty by wriƟ ng an 
essay addressing these criteria and including specifi c examples.  Dr. Stephanie Watowich is the McGovern Outstanding 
Teacher for the 2009-2010 school year.  She has been the Immunology Program Director from 2004-2010, served on 
commiƩ ees for over 70 students and is Chair of the Graduate EducaƟ on CommiƩ ee (GEC).  When her students were asked 
to describe their mentor Dr. Watowich, many described her as accessible, enthusiasƟ c, compassionate and thought-
ful.  Students admire how she “devotes a lot of her Ɵ me oﬀ ering advice on coursework, tutorials, research approaches, 
and even career plans.”
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ement Ceremony
Masters of Science Degree 
2009 - 2010 Graduates
Bonato, Vinicius         (Kim-Anh Do, Ph.D.)
Survival predicƟ on of brain tumor paƟ ents using gene 
expression data
Broadway, Melissa    (Hung Ton-That, Ph.D.)
Molecular basis of corynebacterium diphtheriae virulence and 
infecƟ on in the caenorhabdiƟ s elegans model host
Byers, Lauren              (Gordon Mills, M.D., Ph.D.)
Serum signature of hypoxia-regulated factors is associated with 
progression aŌ er inducƟ on therapy in head and neck squamous 
cell cancer
Cooper, JusƟ ne             (Banu Arun, M.D.) 
Factors associated with early versus late development of breast 
and ovarian cancer in BRCA1 and BRCA2 posiƟ ve women
Caruthers, Douglas   (Geoﬀ rey IbboƩ , Ph.D.)
Commissioning an anthropomorphic spine and lung phantom for 
the remote validaƟ on of insƟ tuƟ ons parƟ cipaƟ ng in RTOG 0631
Crain, Carrie       (Marianna Raia, M.S.)
An assessment of obesity and hyperphagia in individuals with 
Smith-Magenis syndrome
Darnes, Deanna           (Jennifer Czerwinski, M.S.)
First trimester screening and its impact on uptake of diagnosƟ c 
tesƟ ng
Dougall, Triston      (Charles Willis, Ph.D.)
OpƟ mizaƟ on of exposure factors for digital radiography by 
means of CdTe x-ray spectroscopy
Georgiev, Georgi                  (David Followill, Ph.D.)
Comparison of secondary doses in pediatric paƟ ents from 
craniospinal irradiaƟ ons using photon, proton and electron  
spinal fi elds
Giebeler, Annelise          (Wayne Newhauser, Ph.D.)
PaƟ ent specifi c monitor unit determinaƟ on for paƟ ents receiving
proton therapy
Grant, Ryan    (Geoﬀ rey IbboƩ , Ph.D.)
ImplementaƟ on of an anthropomorphic pelvis phantom for the 
evaluaƟ on of proton therapy treatment procedures
Hernandez, Jessica                (Laszlo Radvanyi, Ph.D.)
Improving melanoma tumor-infi ltraƟ ng lymphocyte survival 
and funcƟ on by co-sƟ mulaƟ on through the TNF receptor family 
member 4-1BB
Hui, David                  (Eduardo Bruera, M.D.)
A randomized trial of bilevel posiƟ ve airway pressure device 
and high fl ow oxygen for persistent dyspnea in advanced cancer 
paƟ ents
Hulme, KaƟ e      (S. Cheenu Kappadath, Ph.D.)
ConsideraƟ ons for computed tomography dose reducƟ on in 
Tc-99m SPECT/CT protocols
Murphy, Lauren    (Hope Northrup, M.D.)
Tuberous sclerosis complex and paƟ ent percepƟ ons of 
psychiatric symptoms: a needs assessment
Newman, Leslie       (Louise Strong, M.D.)
Aƫ  tudes of parents towards p53 geneƟ c tesƟ ng in minors
Nguyen, Vuvi       (Andrew Bean, Ph.D.)
The expression and localizaƟ on of CC-Chemokine Receptor 5 
(CCR5) aŌ er traumaƟ c brain injury
Nuccio, Regina    (Claire Singletary, M.S.)
Infl uence of anchoring on miscarriage risk percepƟ on associated 
with amniocentesis
O’Brien, William            (Cheng Lee, Ph.D.)
The physiological and biochemical understanding and 
classifi caiton of 5’-AMP induced deep hypometabolism
Raymond, Aaron            (Lalitha Nagarajan, Ph.D.)
FZD6 and MRS2: Two putaƟ ve MIX1 transcripƟ onal targets
Rotejanaprasert, Chawarat            (Ying Yuan, Ph.D.)
Sample size determinaƟ on for mediaƟ on analysis of longitudinal 
data
Shahzad, Mian Mohammed             (Anil Sood, M.D.)
Targeted delivery of small interfering RNA using rHDL 
nanoparƟ cles
Sirisaengtaksin, Natalie      (Andrew Bean, Ph.D.)
The ubiquiƟ n ligase UBE4B is required for eﬃ  cient epidermal 
growth factor receptor degradaƟ on
Sommer, Amy              (Jacqueline Hecht, Ph.D.)
XenobioƟ c metabolism genes and clubfoot 
Stone, Rebecca               (Anil Sood, M.D.)
The role of platelets in ovarian carcinoma
Vila, Alejandro    (David Marshak, Ph.D.) 
Histamine receptor 1 and 2 expression in primate reƟ nas
Vishwamitra, Deeksha      (Hesham Amin, M.D.)
Type 1 insulin-like growth factor receptor tyrosine kinase as a 
molecular target in mantle cell lymphoma
Wanchoo, Sheshali          (Alan Swann, M.D.)
Role of dopamine of nucleus accumbens in behavioral 
sensiƟ zaƟ on in methylphenidate
            10 
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Abbas, Hussein          (Guillermina Lozano, Ph.D.)
The consequences of disrupƟ ng the MDM2-P53 balance in 
hematopoiesis
Baameur, Faiza        (Richard Clark, Ph.D.)
IdenƟ fi caƟ on of a conserved cluster in the RH domain of GRK 
criƟ cal for acƟ vaƟ on by GPCRs
Babcock, Daniel     (Michael Galko, Ph.D.)
Damage-induced infl ammaƟ on and nocicepƟ ve hypersensiƟ vity 
in Drosophila larvae
Bhalla, Angela                (Miles Wilkinson, Ph.D.)
The mechanism of T-Cell receptor mRNA downregulaƟ on in 
response to nonsense codons
Chen, Meng                (Xifeng Wu, M.D., Ph.D.)
GeneƟ c variaƟ ons in the P13K-AKT-mTOR pathway and bladder 
cancer suscepƟ bility and clinical outcomes
Cheng, Xiaoyun                (Mien-Chie Hung, Ph.D.)
Roles of Akt acƟ vated MDM2 and p21 in mammary 
development and tumorigenesis
Cho, Kyucheol      (Pierre McCrea, Ph.D.)
CharacterizaƟ on of cellular and developmental roles of xenopus 
arvcf-catenin: Kazrin complex
Chou, Chao-Kai                (Mien-Chie Hung, Ph.D.)
The role of AKT-mediated phosphorylaƟ on in suppression of 
MAD1 and the development of new approach in protein complex
detecƟ on
Colby, Jennifer        (Susan Fischer, Ph.D.)
Establishment of a complex infl ammatory and protumorigenic 
microenvironment in mouse pancreas through cyclooxygenase-2 
overexpression
Deng, Binbin        (Z. Hong Zhou, Ph.D.)
Cryo-electron tomography and single parƟ cle cryo-electron 
microscopy: structures of Kaposi’s sarcoma-associated herpesvirus and propionyl CoA carboxylase
Deyter, Gary    (Jill Schumacher, Ph.D.)
ValidaƟ on of the acƟ vaƟ on of aurora B kinase by caenorhabdiƟ s 
elegans tousled-like kinase and the idenƟ fi caƟ on of cyclin B3 as 
a phospho-specifi c TLK-1 interactor
Dupart, Jheri             (Wei Zhang, Ph.D.)
Roles of insulin-like growth factor binding protein-3 in 
gastrointesƟ nal stromal tumors
Ester, Audrey              (Jacqueline Hecht, Ph.D.)
Analysis of variaƟ on in clubfoot candidate genes
Fontenot, Danielle           (Jagannadha Sastry, Ph.D.)
The role of mucosal epithelial cells in HIV infecƟ on
Gomez, Fabiola     (Varsha Gandhi, Ph.D.)
Mechanism-based strategies to enhance the acƟ ons of a HSP90 
inhibitor using mulƟ ple myeloma as a model
Gonzalez-McGehee, Jennifer       (Vasanthi Jayaraman, Ph.D.)
AMPA receptor allosterism: measurement of the conformaƟ onal 
changes in the ligand binding domain of a funcƟ onal receptor
Greathouse, Kristen      (Cheryl Walker, Ph.D.)
Xenoestrogen-specifi c mechanisim of developmental 
reprogramming correlate with gene expression and tumor 
development
Guo, Ruifeng     (David Johnson, Ph.D.)
E2F1’s role in ultraviolet-induced DNA damage response
Gutnisky, Diego    (ValenƟ n Dragoi, Ph.D.)
Dynamic populaƟ on coding in primary visual cortex
Huang, Lulu                (Miles Wilkinson, Ph.D.)
Nonsense-mediated decay: a branched and regulated pathway
Iberg, Aimee          (Mark Bedford, Ph.D.)
From protein mircroarray to biology: the discovery of epigeneƟ c 
regulatory molecules
Irani, Roxanna      (Yang Xia, M.D., Ph.D.)
Preeclampsia, autoimmunity and the AT1 receptor
Jen, Emily               (Elizabeth Grimm, Ph.D.)
IL-2 regulates IL-24 protein expression leading to growth 
suppression of melanoma
Jeter, Cameron         (Anne Sereno, Ph.D.)
Eye movement measures of cogniƟ ve control in children with 
ToureƩ e Syndrome
Jia, Zhiliang               (Keping Xie, M.D., Ph.D.)
Targeted inhibiƟ on of Sp1 transcripƟ on factor and 
anƟ -angiogenesis of human pancreaƟ c cancer
Kapuria, Vaibhav              (Nicholas Donato, Ph.D.)
InhibiƟ on of DeubiquiƟ nase acƟ vity and UbiquiƟ naƟ on of Jak2 
blocks cytokine signaling and induces tumor cell apoptosis
Kim, Tae Kon           (Krishna Komanduri, M.D.)
The role of MAP kinases on the funcƟ onal heterogeneity of 
human CD8+ T cell maturaƟ on subsets
Kopetz, E. ScoƩ           (Gary Gallick, Ph.D.)
The role of acƟ vaƟ on of the protein tyrosine kinase, Src, in 
colorectal cancer chemoresistance
2009-2010 Graduates
Doctor of Philosophy Degree
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Doctor of Philosophy Degree 
2009 - 2010 Graduates
Kothmann, William        (John O’Brien, Ph.D.)
RegulaƟ on of connexin 36-mediated coupling by 
phosphorylaƟ on
Kurinna, Svitlana               (Michelle Barton, Ph.D.)
New target genes for tumor suppressors p53 and p73 in 
regeneraƟ ng liver
Latham, Leigh             (Roger Janz, Ph.D.)
Protein-protein interacƟ ons that regulate neurotransmiƩ er 
release from reƟ nal ribbon synapses
Lee, Alessandro            (Wadih Arap, M.D., Ph.D.)
PC-TSGC: a new cell-growth suppressor gene regulated by the 
ncRNA PCA3 in prostate cancer
Li, Yufeng                        (Patrick Hwu, M.D.)
Studies on melanoma tumor-infi ltraƟ ng lymphocytes to 
improve adopƟ ve T-cell therapy
Lin, Qingtang          (Isaiah Fidler, Ph.D., D.V.M.)
The role of reacƟ ve astrocytes in the resistance of melanoma 
brain metastasis to chemotherapy
Lu, Ming       (Xiaomin Chen, Ph.D.)
Macromolecular interacƟ on studies on FF1-3 of human CA150 
and STAT1-imporƟ n alpha5 using biophysical and biochemical 
methods
Meadows, James       (William Klein, Ph.D.)
Myogenin modulates exercise endurance by altering skeletal 
muscle metabolism
Melancon, Adam               (Lei Dong, Ph.D.)
Range adapƟ ve proton therapy for prostate cancer
Molina, Jennifer       (Maria-Magdalena Georgescu, M.D., Ph.D.)
NHERF1 recruits the tumor suppressors PTEN and PHLPP to 
synergisƟ cally inhibit the Pl-3K pathway
Papke, ChrisƟ na   (Dianna Milewicz, M.D., Ph.D.)
Smooth muscle hyperplasia due to ACTA2/MYH11 mutaƟ ons: 
idenƟ fi caƟ on of novel pathology and pathways leading to 
aneurysms and diverse vascular occlusive diseases
Park, Hyun Jun              (Larry Kwak, M.D., Ph.D.)
Eﬃ  cacy and mechanism of beta-defensin2 fused anƟ gen 
protein vaccines
Pichot, ChrisƟ na             (Seth Corey, M.D.)
CIP4 and Src in promoƟ ng the migraƟ on and invasion of breast 
cancer
Ragan, DusƟ n    (James Bankson, Ph.D.)
Measurement of the vascular input funcƟ on in mice for DCE-MRI
Ramirez, Melissa    (Michael Lorenz, Ph.D.)
AlternaƟ ve carbon metabolism: virulence and regulaƟ on in 
candida albicans
Riegel, Adam               (Tinsu Pan, Ph.D.)
Thoracic radiotherapy treatment planning with Cine PET/CT
Schneider, Daniel           (Michael Blackburn, Ph.D.) 
OsteoponƟ n and cadhedrin 11 are novel mediators and drug 
targets for chronic lung diseases
Shaw, Joanne            (Yong-Jun Liu, M.D., Ph.D.)
The role of plasmacytoid dendriƟ c cells in the regulaƟ on of 
adapƟ ve immunity
Smith, Debra         (Gordon Mills, Ph.D.)
GSK3 mediates signaling upstream of Akt
Song, Hye Won                 (Miles Wilkinson, Ph.D.)
TranscripƟ onal and translaƟ onal regulators of gene expression 
in germ cell development
Spellicy, Catherine    (Stephen Daiger, Ph.D.)
InvesƟ gaƟ ng the pathogenicity of mutaƟ ons in two ubiquitously 
expressed housekeeping genes that cause autosomal dominant 
reƟ niƟ s pigmentosa
Stewart, Keri          (Eugenie Kleinerman, M.D.)
Delta like ligand 4 is a criƟ cal regulator of bone marrow cell 
diﬀ erenƟ aƟ on into pericytes/vascular smooth muscle cells and is 
essenƟ al for the vasculogenesis that supports growth of Ewing’s 
sarcoma
Sundberg, Laura          (Ponnada Narayana, Ph.D.)
In vivo longitudinal evaluaƟ on of spinal cord injury and the 
eﬀ ects of vascular endothelial growth factor treatment
Swulius, MaƩ hew             (M. Neal Waxham, Ph.D.)
Developmental changes in the structure and composiƟ on of the 
postsynapƟ c density
Vazquez, Vanessa      (Magnus Hook, Ph.D.)
Host-pathogen interacƟ ons of secreted and surface factors of 
Staphylococcus aureus
Wang, Yongxing          (Guillermina Lozano, Ph.D.)
TherapeuƟ c potenƟ al of P53 restoraƟ on in spontaneous tumors
Yang, Cheng-Chieh               (Mien-Chie Hung, Ph.D.)
Polycomb repressive complex 2 induced basal-like breast cancer 
phenotye mediated by cyclin E/CDK2
Zhou, Yang            (Michael Blackburn, Ph.D.)
The role of A2bR signaling in adenosine dependent lung disease
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Biochemistry and Molecular Biology
UTHealth Medical School
Ph.D., Columbia University, 2003
Research interests: molecular mechanism of the 
circadian clock; clock-related pathophysiology 
including aging, cancer, CVD and metabolic disease; 
small molecules as research tools and therapeuƟ c 






Ph.D., Rutgers University, 2000
Research interests: developmental neuroscience; 
mouse disease models; reƟ na and eye development; 




Center for Immunology and Autoimmune Diseases
UTHealth InsƟ tute of Molecular Medicine
Ph.D., Seoul NaƟ onal University, 2003
Research interests: T cell diﬀ erenƟ aƟ on by innate
immune system; regulaƟ on of mucosal immunity; 
cytokines in infl ammaƟ on and cancer; plasƟ city of T 





M. D. Anderson Cancer Center
Ph.D., Purdue University, 1992
Research interests: signal transducƟ on; structure/
funcƟ on of proteins; NF-κB transcripƟ on factors; 
osteoclast development; leukemia; ubiquiƟ n, E3 
ubiquiƟ n ligases, and deubiquiƟ nases
Catherine Denicourt
Assistant Professor
IntegraƟ ve Biology and Pharmacology
UTHealth Medical School
Ph.D., University of Montreal, 2003
Research interests: cell cycle regulaƟ on and cancer; 
cyclin and cyclin-dependent kinases; oncogenes and 




M. D. Anderson Cancer Center
M.D., ChrisƟ an Medical College (India), 1993
Research interests: molecular imaging of cancers; 
image guided therapy; hyperthermia; 







M. D. Anderson Cancer Center
Ph.D., All India InsƟ tute for Medical Sciences, 2002
Research interests: germline development and mor-
phogenesis of oogenesis; RAS/ERK signaling pathways 
governing germ cell development; developmental 
signaling networks (ERK-substrate networks); evoluƟ on 
of developmental pathways; C. elegans geneƟ cs
Robert C. Bast, Jr.
Professor 
Experimental TherapeuƟ cs
M. D. Anderson Cancer Center
M.D., Harvard Medical School, 1971
Research interests: ovarian and breast cancer early 
detecƟ on; biomarkers; paclitaxel sensiƟ vity; imprinted 
tumor suppressor genes; autophagy; tumor dormancy
Perry E. Bickel
Associate Professor
UTHealth InsƟ tute of Molecular Medicine 
UTHealth Medical School (Department of Medicine)
M.D., UT Southwestern, 1988
Research interests: adipocyte biology; obesity; diabetes 




UTHealth InsƟ tute of Molecular Medicine
M.D., Duke University School of Medicine, 1963
Research interests: inherited disease and mammalian 
geneƟ cs; drug development; vaccine development; cell 











MEMBERS REAPPOINTED WITH 
HIGHEST COMMENDATION
MEMBERS REAPPOINTED WITH 
VERY HIGHEST COMMENDATION
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M. D. Anderson Cancer Center
Ph.D., UTHealth Graduate School of Biomedical Sci-
ences, 2007
Research interests: out-of-fi eld dose; peripheral 




Internal Medicine – InfecƟ ous Diseases
UTHealth Medical School
Ph.D., University of Arizona, 1978
Research interests: HIV immunology and pathogene-
sis; mechanisms of chronic acƟ vaƟ on in HIV; mecha-
nisms of HIV-associated lipodystrophy; microparƟ cles 
in maternal plasma for fetal geneƟ c diagnosis; mech-





Ph.D., UTHealth GSBS, 2000
Research interests: human geneƟ cs; molecular 
pathogenesis of vascular diseases (including cardio-
vascular and cerebrovascular disease) 
Lidong Qin
Assistant Professor
Nanomedicine and Biomedical Engineering
UTHealth Medical School
Ph.D., Northwestern University, 2007
Research interests: biomedical nanotechnology; can-




Nanomedicine and Biomedical Engineering
UTHealth Medical School
Ph.D., University of New Mexico, 2006
Research interests: nanomedicine; drug delivery; 





M.D., Armed Forces Medical College, 1992
Research interests: human language; funcƟ onal mag-
neƟ c resonance imaging (fMRI); electrical corƟ cal 
sƟ mulaƟ on mapping; intra-cranial EEG; diﬀ usion trac-
tography (DTI); funcƟ onal defi cits caused by epilepsy 
and epilepsy surgery
Ennio Tascioƫ  
Assistant Professor
NanoMedicine and BioMedical Engineering
UTHealth Medical School
Ph.D., Scuola Normale Superiore Pisa, 2005
Research interests: nanotechnology; molecular 
medicine; drug delivery; early diagnosis of diseases; 
proteomic profi ling; Ɵ ssue engineering
S. Ray Taylor
Professor
RestoraƟ ve DenƟ stry and Biomaterials
UTHealth Dental Branch
Ph.D., University of Virginia, 1986
Research interests: biomaterials; coaƟ ngs and sur-
face modifi caƟ on; molecular interacƟ ons at surfaces; 




Biochemistry and Molecular Biology
M. D. Anderson Cancer Center
Ph.D., University of Glasgow, 1994
Research interests: epigeneƟ cs; cancer; aging; DNA 




InsƟ tute of Molecular Medicine
Ph.D., Yale University, 2001
Research interests: mechanisms of neuronal degener-
aƟ ve disorders; HunƟ ngton’s disease (HD) and the nor-
mal funcƟ ons of the HD gene HunƟ ngƟ n; Parkinson’s 
disease (PD); intracellular handling of neurotransmit-




IntegraƟ ve Biology and Pharmacology
UTHealth Medical School
Ph.D., University of Houston, 1991
Research interests: G proteins; ion channels; 
receptors; calcium signaling; neurotransmiƩ ers; 





M. D. Anderson Cancer Center
Ph.D., Rice University, 1990
Research interests: scienƟ fi c communicaƟ on; scienƟ fi c 
wriƟ ng; internaƟ onal scienƟ sts (ESL and cross-




M. D. Anderson Cancer Center
Ph.D., Baylor College of Medicine, 1995
NEW ASSOCIATE MEMBERS
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Research interests: experimental cancer 
therapeuƟ cs and in vivo modeling; anƟ cancer drug 
development and Good Laboratory PracƟ ces (GLP); 
mechanisms of drug/radiaƟ on sensiƟ vity and resis-
tance in cancer cells; cancer cell diﬀ erenƟ aƟ on as a 
therapeuƟ c approach, funcƟ onal genomics
Mehran Haidari
Assistant Professor
Internal Medicine – Cardiology
UTHealth Medical School
Ph.D., Tehran University of Medical Sciences, 2002
Research interests: vascular biology of 
atherosclerosis; endothelial cells dysfuncƟ on; recruit-
ment of leukocyte to infl amed 
vasculatures; the role of acƟ n cytoskeleton in interac-
Ɵ on of endothelial cells and monocytes; cholesterol-





Ph.D., UTHealth School of Public Health, 2008
Research interests: epidemiology of birth 
defects; maternal exposures during pregnancy; 





M. D. Anderson Cancer Center
Ph.D., Beijing Normal University, 1997
Research interests: oncolyƟ c adenoviruses; 




Internal Medicine – InfecƟ ous Diseases
UTHealth Medical School
M.D., Universidad Autonoma de Guadalajara, 1985
Research interests: human geneƟ cs and 
suscepƟ bility to infecƟ ous diseases; pathogenesis and 
host immune response to the 
enteropathogens Cryptosporidium and 
enteroaggregaƟ ve E. coli
Alexandria T. Phan
Associate Professor
GastrointesƟ nal Medical Oncology
M. D. Anderson Cancer Center
M.D., University of California, Irvine – College of Medi-
cine, 1997
Research interests: GI medical oncology
Nicole K. Ruddock
Assistant Professor
Obstetrics & Gynecology – Maternal-Fetal 
Medicine
UTHealth Medical School
M.D., University of Miami School of Medicine, 2002
Research interests: preterm birth; medical 






Ph.D., University of ConnecƟ cut Health Center, 2005





M. D. Anderson Cancer Center
M.D., Beijing Medical University, 1990
Ph.D., University of Wisconsin-Madison, 1998
Research interests: acute myeloid leukemia; chronic 
myelogenous leukemia; molecular 
leukemogenesis, monitoring and targeƟ ng





























          Oﬃ  cers 
Welcome!
2010-2011 
          Oﬃ  cers 
 |  Find more about GSA meeƟ ngs and events hƩ p://www.uthouston.edu/gsbs/current-students/student-life/gsa/  | 
        { Please submit news items to Laura.Sanders@uth.tmc.edu  }
   Faculty News              
At the most recent M. D. Anderson Faculty ConvocaƟ on, the 
following faculty members were recognized:
Endowed Professorships
ChrisƟ an Abee, D.V.M. - • Doctor R. Lee Clark Professorship
Bharat Aggarwal, Ph.D. - • Ransom Horne, Jr., Professorship  
 for Cancer Research
Wadih Arap, M.D., Ph.D. - • Hubert L.  and Olive Stringer 
 Professorship for Cancer Treatment and Research
Varsha Gandhi, Ph.D. - • Ashbel Smith Professorship
Elizabeth Grimm, Ph.D. - • Frances King Black Memorial 
 Professorship for Cancer Research
Jean-Pierre Issa, M.D. - • Bessie McGoldrick Professorship in  
 Clinical Cancer Care
Khandan Keyomarsi, Ph.D. -•  Hubert L. and Olive Stringer 
 Professorship in Medical Oncology
Jonathan Kurie, M.D. - • Elza A. and Ina Shackelford Freeman  
 Endowed Professorship in Lung Cancer
Karen Lu, M.D. - • H.E.B. Professorship in Cancer Research
Marvin Meistrich, Ph.D. - • Florence Maude Thomas Cancer  
 Research Professorship
Raymond Meyn, Jr., Ph.D. - • Kathryn O’Conner Research 
 Professorship
Jefrrey Myers, M.D., Ph.D. - • Ashbel Smith Professorship
Renata Pasqualini, Ph.D. - • Helen Buchanan and Stanley 
 Joseph Seeger Research Professorship
Elizabeth Travis, Ph.D. - • Maƫ  e Allen Fair Professorship in  
 Cancer Research
Stephen Ullrich, Ph.D. - • Dallas/Fort Worth Living Legend  
 Professorship
Cheryl Walker, Ph.D. - • Ruth and Walter Sterling 
 Professorship
Edward Yeh, M.D. - • A ConversaƟ on with a Living Legend 
 Professorship
Endowed DisƟ nguished Professorships
Jonas Almeida, Ph.D. - • Abell-Hanger FoundaƟ on 
 DisƟ nguished Professorship
Christopher Amos, Ph.D. - • Annie Laurie Howard 
 DisƟ nguished Professorship
Laurence Cooper, M.D., Ph.D. - • H. Grant Taylor, M.D., W. W.  
 Sutow, M.D., and Margaret P. Sullivan, M.D. DisƟ nguished  
 Professorship in Pediatrics
Walter HiƩ elman, Ph.D. - • Sophie Caroline Steves 
 DisƟ nguished Professorship in Cancer Research
John Ladbury, Ph.D. - • Edward Rotan DisƟ nguished 
 Professorship in Cancer Research
Jeﬀ rey Molldrem, M.D. - • Virginia H. Cockrell DisƟ nguished  
 Professorship in Immunology
Hui-Lin Pan, M.D., Ph.D. - • N. G. and Helen T. Hawkins 
 DisƟ nguished Professorship for Cancer Research
Anil Sood, M.D. - • BeƩ yann Asche Murray DisƟ nguished 
 Professorship in Ovarian Cancer Research
Richard Wood, Ph.D. - • Grady F. Saunders, Ph.D. 
 DisƟ nguished Professorship in Molecular Biology
Dihua Yu, M.D., Ph.D. - • Nylene Eckles DisƟ nguished 
 Professorship in Breast Cancer Research
Faculty Achievement Awards were given to Guillermina 
Lozano, Ph.D., Karen Lu, M.D., and William MaƩ ox, Ph.D.
GSBS faculty members have been awarded research grants from 
the Cancer PrevenƟ on & Research InsƟ tute of Texas (CPRIT) in the 
following categories:
Sharon Dent, Ph.D. has been appointed Chair of Carcinogenesis 
and administraƟ ve director of the Science Park, Research Division 
in Smithville eﬀ ecƟ ve August 1, 2010.  She will also be professor 
of Carcinogenesis and conƟ nue to serve as co-director for the 
Center for Cancer EpigeneƟ cs. 
Larry Kwak, M.D., Ph.D. has been recognized for his 20-year 
commitment to the science of cancer vaccines and named to 
TIME magazine’s list of the 100 most infl uenƟ al people in the 
world.  This list recognizes acƟ vism, innovaƟ on and achievement.
Wadih Arap, M.D., Ph.D., Renata Pasqualini, Ph.D., and 
Maria-Magdalena Georgescu, M.D., Ph.D. are co-authors on a 
study that revealed a new technique for growing 3-D cell cultures, as 
opposed to the fl at petri dish that could save millions of dollars
in drug-tesƟ ng costs.  Other co-authors include James Bankson, 
Ph.D., and Juri Gelovani, M.D., Ph.D., along with GSBS students 
Jennifer Molina, Michael Ozawa and Lawrence Bronk, who 
contributed to this study that was reported in Nature 
Nanotechnology in March 2010. (Editor’s Note: This material has 
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   Student News
The John P. McGovern Award for PresentaƟ on Skills was designed 
and conducted by the Student Aﬀ airs CommiƩ ee, who believed 
that students needed to be encouraged to develop presentaƟ on 
(oral and wriƩ en) skills.  The winners this year:
 Student   Advisor
1st Jessica Bowser  Dr. Russell Broaddus
2nd Kedryn Baskin  Dr. Heinrich Taegtmeyer
3rd Sharat VayƩ aden  Dr. Richard Clark 
The Graduate School has won the 2010 United to Serve Volunteer Day 
Award for having the highest number of parƟ cipants in the University 
of Texas System’s “United to Serve” volunteer projects.  This eﬀ ort is 
organized each year through the Student InterCouncil.
                                         Student Awards
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Harry S. & Isabel C. Cameron Foundation Fellowship
The Cameron FoundaƟ on provides a fellowship to an excepƟ onal post-candidacy student working in research 
fi elds related to Alzheimer’s or cardiovascular diseases.  The FoundaƟ on giŌ  of $15,000 is matched by GSBS and Faculty. 
The 2009-2010 recipient is:
 Student   Advisor
 Rui Zhang  Dr. Chun Li
Aaron Blanchard Research Award in Medical Physics
Named in memory of Aaron M. Blanchard, a GSBS student in the Medical Physics Program who succumbed to brain cancer 
in 1998, this $500 cash award recognizes a Medical Physics graduate (M.S. or Ph.D.) for compleƟ on of an outstanding thesis or 
dissertaƟ on judged to make a signifi cant contribuƟ on to cancer therapy or diagnosis. This year’s recipient is:
 Student    Advisor
 Malcolm Heard   Dr. Geoﬀ rey IbboƩ 
Michael Farley Moyers Endowed Heavy Particle Therapy Travel Award
In 2006 GSBS Alumnus Michael F. Moyers, Ph.D. (1991/Horton) created this award for an excepƟ onal Medical Physics student 
who has had a paper accepted at the American AssociaƟ on of Physicists in Medicine (AAPM) to aƩ end the annual meeƟ ng. 
Adam Melancon received fi rst place in the John R. Cameron Young InvesƟ gator CompeƟ Ɵ on for his dissertaƟ on Ɵ tled 
Range AdapƟ ve Proton Therapy for Prostate Cancer, and in turn received $750 this year.
 Student    Advisor
 Adam Melancon   Dr. Lei Dong
Andrew Sowell-Wade Huggins Endowed Scholars, 
Professor and Fellows
Cancer Answers/Sylvan Rodriguez Scholars
The Andrew Sowell-Wade Huggins Scholars, Professor and Fellow, and the Cancer Answers/Sylvan Rodriguez Scholars represent the 
culminaƟ on of nineteen years of determined support and growth of the Cancer Answers charitable organizaƟ on through two founding 
mothers, Joann Sowell and Marcia Huggins Jahncke, their families, cancer survivors, and contribuƟ ng foundaƟ ons including the Vivian L. 
Smith FoundaƟ on, Sylvan Rodriguez ChariƟ es, and especially Bobby Sue Smith Cohn and Bo and Amy Huggins.  Originally started as the 
fundraising enƟ ty to support the Andrew Sowell-Wade Huggins Endowment which generates support for all of these awards to fund grad-
uate educaƟ on in cancer research, it has gained in size and presƟ ge.  Since 1991 over 50 scholars and 4 sets of professor/fellow teams 
(renewable up to three years) have been honored with awards ranging from $3,000 scholarships up to $20,000 in sƟ pend support. 
The 2009-2010 Sowell-Huggins Endowed Scholars receiving $5,000 are:
 
The 2009-2010 Cancer Answers/Sylvan Rodriguez Scholar is:
Student   Advisor
Liem Phan (far leŌ ) Dr. Mong-Hong Lee
Student   Advisor
Lenka Hurton  Dr. Laurence Cooper
Sumaiyah Rehman Dr. Dihua Yu
Aman Mann  Dr. Mauro Ferrari 
Brian Taylor  Dr. Jason Staﬀ ord
Rui Zhang  Dr. Wayne Newhauser
Erika Spaeth  Dr. Frank Marini
The 2009-2010 Professor/Fellow team is:
Student   Advisor
Angela Alexander  Dr. Cheryl Walker
Endowed Scholars and Professor/Fellow team is pictured here with 
Amy Huggins (front leŌ ), Joann Sowell and Marcia Huggins Jahncke 
(front center).
| GSBS Fiesta         REUNION        
2010       
|
I received my Ph.D. in 1973 (under Dr. Carl Tessmer; Pathology).  I took postdoctoral training (with Dr. Burr 
Furlong;Biochemistry), and then worked for 12 ½ years as a toxicologist at Shell and have worked since 1990
as a health and environmental consultant.  A few years ago, I began to develop post-polio syndrome – a progressive 
and irreversible return of the paralysis of my childhood. This forced me to rethink my career once again, 
and I created a company dedicated to providing clean water to communities and businesses around the world, 
CleanBlue Water, LLC.
My professional life has taken me into the full range of biomedical issues, as well as into regulatory negotiation, 
expert witness testimony, even into the minutia of business and management.  I have repeatedly been struck by how well my education
at GSBS prepared me to be successful.  Linda Carter asked me what insights I would offer our current students. I think that 
my experience can be summarized in one piece of advice:
Understand that you absolutely control the level of success that you will achieve in your career and in your life.  Any problem 
should be approached by a) identifying the objective (specifi c and measurable); b) planning in detail what actions must be taken 
to achieve that objective; and c) having the courage to implement the plan.  If you are not successful on your fi rst attempt, 
evaluate what went wrong, modify the plan, and try it again.  Life will undoubtedly put hurdles in your way, but none are higher 
than those you create for yourself by saying that you can’t do something.  
 Alumni News                     
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Hillside home of Alumna 
BethLynn Maxwell, Ph.D. (1980/T.C. Hsu), J.D.
AusƟ n, Texas
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Alumni Spotlight                 Ben Thomas, Ph.D.    (Tessmer/1973) 
Stephen HewiƩ , Ph.D. 
(Saunders/1991), M.D. and his 
wife, Mercedes celebrate the birth 
of their son Spencer Judson Parker 
HewiƩ , born May 19.  Spencer is 
pictured here with their daughter, 
Merrill.
MaƩ hew Lewin, M.D., Ph.D. (Walters/1992) was featured in 
the July 2010 issue of Nature.  Lewin describes how his dual 
degrees have come in handy in his line of work: wilderness 
medicine.  The arƟ cle highlights the chapter he co-authored
in Wilderness Medicine, “Wilderness PreparaƟ on Equipment,
and Medical Supplies,” and what he views as the most 
important supplies to carry in a medical kit.
 NewsleƩ er            Editor: Linda Carter             Photography: Linda Carter, Dwight Andrews, Laura Sanders
                 Graphic Design: Laura Sanders                                    
All giŌ s at any scale and to any category:
Will be acknowledged. 
Are tax deducƟ ble. 
May be matched by a corporaƟ on to enhance
 the value of your giŌ . 
May be used for memorial giŌ s to honor a favorite faculty, 
family member or friend.  A noƟ ce will be sent to inform
 the family of the honor (not the amount) of your giŌ , and 
you will be acknowledged individually.
Consider a charitable giŌ  annuity to increase
 your reƟ rement earnings.
The easiest way to give is to designate the
 Graduate School as benefi ciary of all or part of the 
balance of your estate.  All bequests and benefi ciary
 designaƟ ons should be made to “Board of Regents 
of the University of Texas Stsem for the benefi t of 
The University of Texas Graduate School of Biomedical 
Sciences at Houston.  This giŌ  shall be used for
 the further benefi t of the School and shall be 
used to .”

















Special Thanks and Gratitude
American Legion Auxiliary




The Schissler FoundaƟ on
The William A. and Madeline Welder Smith FoundaƟ on
    Our Benefactors                       
Staﬀ  News
Lisa joined the GSBS in February 2010 to coordinate all aspects of the Center for Clinical and TranslaƟ onal 
Science (CCTS) T32 translaƟ onal research training grant. Previously, Lisa worked at M. D. Anderson Cancer 
Center and has a total of over 20 years working in large academic medical insƟ tuƟ ons. She lives with her 
17 year old daughter and their two small dogs in the Museum District. Lisa spends much of her leisure Ɵ me 
chaperoning her daughter who is a professional Hannah Montana impersonator. Born, raised and college 
educated in Oregon, Lisa now considers herself a true Texan.
New GSBS Staﬀ  Member: Lisa WeƩ er, CCTS Senior AdministraƟ ve Coordinator
Brenda Gaughan (right), Faculty Aﬀ airs, is the 2010 Recipient of the GSBS Melva S. Ramsay 
Award for outstanding service to faculty, students and staﬀ .  The award of $500 (and plaque) is 
presented by George Stancel, Dean, in memory of Melva Ramsay, long Ɵ me beloved employee 
of GSBS.
Melva S. Ramsay Award
Our Contributors
∞
The University of  Texas Health Science Center at Houston
The University of Texas M. D. Anderson Cancer Center
Graduate School of Biomedical Sciences
PO Box 20334  
Houston, Texas 77225-0334
Deadline for news to be included in the next newsleƩ er is February 1, 2011
Hello Alumni,
CongratulaƟ ons to Cathy Wicklund, M.S. in GeneƟ c Counseling (1993/Hecht), who is the newly named DisƟ nguished Alumna for 2010-2011.  Please 
plan to join me and other GSBS alumni and colleagues for the annual Alumni Reunion, Friday, November 19 at Trevisio Restaurant.  Ms. Wicklund, M.S., 
C.G.C., is currently Director of the GeneƟ c Counseling Program at Northwestern University, Department of Obstetrics and Gynecology, Chicago, Illinois. 
She is a past president of the NaƟ onal Society of GeneƟ c Counselors, has served or currently serves on the Health Resources & Services AdministraƟ on, 
U.S. Department of Health & Human Services, the GeneƟ cs Task Force of Illinois and the American Board of GeneƟ c Counseling, among other naƟ onal 
roles and honors.
As your Alumni president I have had the privilege of welcoming 67 graduates at the May Commencement into the “fold” of 
this esteemed group—the Graduate School of Biomedical Sciences Alumni AssociaƟ on.  We are growing, with now over 2,000 
alumni, nearly 500 in the Houston area with the rest across the United States and around the world.  GSBS alumni refl ect 
leadership in academia, educaƟ on, pharmaceuƟ cal and biotech industries, oil and energy corporaƟ ons, governmental agencies, 
the media, and law oﬃ  ces with intellectual property experƟ se.  It was terrifi c to see the confi dent soon-to-be alumni at the 
“GraduaƟ on CelebraƟ on,” which the Alumni AssociaƟ on hosts a few nights before Commencement.  This year’s group received 
nearly 50 named scholarships, fellowships or other awards of excellence during their Ɵ me at GSBS—several supported by 
Alumni donaƟ ons.  Thank you!
Thank you to my partners in this eﬀ ort, the Alumni AssociaƟ on Steering CommiƩ ee: Vicky Estrera, Ph.D. (2001) president 
ex-oﬃ  cio; Jackie PelƟ er Horn, Ph.D. (1981) president-elect; Dorrie Lamb, Ph.D., (1980); Ben Thomas, Ph.D., (1973); Mollianne McGahren Murray, 
Ph.D., (2007); and new members Sol Bobst, Ph.D. (2003); and Dianne Hammond, Ph.D. (1989). Among other exciƟ ng programs they energized this 
year were a very successful Career Day, and the kickoﬀ  for the new and improved interacƟ ve website, alive and well as of April 1—hooray!  Please 
log-in and sign up today—you are able to edit your own contact and other informaƟ on to stay current as well as gather/post the latest news 
www.utgsbsalumni.org.
Special thanks to Dean Stancel. I personally appreciate his foresight in starƟ ng the Alumni AssociaƟ on and providing conƟ nued support that strengthens 
the organizaƟ on and the School.  Thank you to BethLynn Maxwell, Ph.D. (1980) and hubby Stephen Reed for hosƟ ng a wonderful Fiesta for AusƟ n-area 
alums in their beauƟ ful home —it was great to visit with all!  
Enjoy these last days of summer and mark your calendars for November 19th!
Best wishes,
Joy Marshall, Ph.D. (2003)
GSBS Alumni AssociaƟ on President
2009-2010
Address Correction Requested
